SummerHaven Investment Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,400	Closed	-$570K	–	203
2024 Q2	$570K	Buy	23,400 +409	+2%	+$9.96K	0.37%	150
2024 Q1	$776K	Buy	22,991 +287	+1%	+$9.69K	0.49%	115
2023 Q4	$716K	Buy	22,704 +378	+2%	+$11.9K	0.46%	131
2023 Q3	$570K	Buy	+22,326	New	+$570K	0.42%	163